• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:
    Use of a casein hydrolyzate as an antiviral agent. The present invention relates to the use of a casein hydrolyzate as an antiviral agent for the treatment of infections by opportunistic viruses, especially herpesviruses and human papillomavirus. Said casein hydrolyzate has application both in the therapeutic treatment of established symptoms and in the prevention of infection or the reactivation of a latent infection by an opportunistic virus. The casein hydrolyzate of the present invention is effective for the prevention of opportunistic virus infections in individuals with weakened immune systems. (Machine-translation by Google Translate, not legally binding)
    公开号:ES2544153A1
    申请号:ES201430248
    申请日:2014-02-24
    公开日:2015-08-27
    发明作者:Pere ADELL WINKLER；Guillermo LÓPEZ ZARCO
    申请人:NTD LABS S L；NTD LABS SL；
    IPC主号:
    专利说明:

    image 1
    image2
    image3
    image4
    image5
    image6
    image7
    image8
    image9
    image10
    image11
    image12
    image13
    image14
    image15
    image16
    权利要求:
    Claims (1)
    [1]
    image 1
    image2
    类似技术:
    公开号 | 公开日 | 专利标题
    BR112017014209A2|2018-03-06|dental system design aided by computer system
    CL2015003298A1|2016-06-17|Novel bridged heteroaryl dihydropyrimidines in 6 for the treatment and prophylaxis of hepatitis B virus infection
    BR112017005104A2|2017-12-05|5,6-dihydro-4h-benzothieno- [2,3-d] azepine derivative
    CR20150337A|2015-11-02|DERIVATIVES OF PIRIMIDINONE AND ITS USE IN THE TREATMENT, IMPROVEMENT OR PREVENTION OF A VIRAL DISEASE
    PH12017500207B1|2017-07-10|Indoles for use in influenza virus infection
    CL2015000784A1|2015-06-12|Compounds derived from acylaminopyrimidine, interferon inducers; pharmaceutical composition that includes them; its use in the treatment of viral infections, immune disorders, cancer and other diseases.
    BR112017004524A2|2017-12-05|pyrrolopyrimidines for use in influenza virus infection
    UA121199C2|2020-04-27|Aza-pyridone compounds and uses thereof
    BR112015029264A2|2017-07-25|device location using camera and wireless signal
    MX370085B|2019-11-29|Pyridazinone compounds and uses thereof.
    EA201490610A1|2014-09-30|CONNECTIONS AND METHODS OF STRENGTHENING CONGENITAL IMMUNE RESPONSES
    TR201911232T4|2019-08-21|Topical compositions containing the extract of coriolus versicolor for the development of autoimmunity.
    BR112019009256A2|2019-07-16|methods for treating alport syndrome using methyl bardoxolone or analogs thereof
    WO2016191363A8|2017-10-12|Combination hiv therapeutic
    MA51630A|2020-01-22|USE OF ONCOLYTIC VIRUSES, ALONE OR IN COMBINATION WITH AN IMMUNE CHECKPOINT INHIBITOR, FOR THE TREATMENT OF CANCER
    ES2544153A1|2015-08-27|Use of a casein hydrolyzate as an antiviral agent |
    EA201692514A1|2017-04-28|PHARMACEUTICAL COMPOSITIONS ON THE BASIS OF SOFOSBUVIR AND RIBAVIRIN WITH MODIFIED FREEDOM
    CY1119674T1|2018-04-04|Alzheimer's Disease Treatment and Prevention |
    UA123054C2|2021-02-10|Composition having antiviral effect
    EA201792124A1|2018-04-30|BIOTIN FOR THE TREATMENT OF AMIOTROPHIC LATERAL SCLEROSIS
    BR112017011168A2|2018-01-02|medicines to slow parkinson's disease
    MX2016016865A|2017-07-27|Reduction of infections in healthcare settings using photocatalytic compositions.
    CL2014003048A1|2015-07-17|Compounds derived from n - [| amino] -9,10-dihydro-4, 5-dihydroxy-9,10-dioxoanthracene-2-carboxamide; procedure to prepare them; pharmaceutical composition; intermediary compounds; and use for the prevention and / or treatment of Alzheimer's disease.
    DK2941269T3|2021-01-11|Therapeutic vaccines for the treatment of herpes simplex virus type 2 infections
    EA201591397A1|2015-11-30|CINOXALINONES AND DIHYDROCHINOXALINONS AS ANTI-VIRUS MEANS AGAINST RESPIRATORY-SYNCYTIAL VIRUS
    同族专利:
    公开号 | 公开日
    DK3110430T3|2019-09-23|
    PT3110430T|2019-10-15|
    US10772927B2|2020-09-15|
    ES2544153B1|2016-06-06|
    US20160361374A1|2016-12-15|
    ES2746523T3|2020-03-06|
    EP3110430B1|2019-06-26|
    WO2015125067A1|2015-08-27|
    EP3110430A1|2017-01-04|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    WO2002045524A2|2000-12-07|2002-06-13|Dsm Ip Assets B.V.|Prolyl endoprotease from aspergillus niger|
    US20110082281A1|2003-08-01|2011-04-07|Calpis Co., Ltd.|Casein hydrolyzate, process for producing the same and use thereof|
    WO2011138489A1|2010-05-06|2011-11-10|Consejo Superior De Investigaciones Científicas |Use of casein hydrolysates as antiviral agents|
    DE3922453A1|1989-07-07|1991-01-17|Gauri Kailash Kumar|Prod. extracted from milk protein hydrolysate - for topical treatment of herpes simplex virus infections|
    AU668088B2|1991-04-01|1996-04-26|Cytran Ltd.|Pharmaceutical dipeptide compositions and methods of use thereof|
    WO1998046077A1|1997-04-15|1998-10-22|Advanced Viral Research Corp.|A method for treating papillomavirus infections|
    WO2000001720A2|1998-07-02|2000-01-13|President And Fellows Of Harvard College|Compositions and methods for treating papillomavirus-infected cells|
    IL134830D0|2000-03-01|2001-05-20|Chay 13 Medical Res Group N V|Peptides and immunostimulatory and anti-bacterial pharmaceutical compositions containing them|
    TWI317636B|2002-11-22|2009-12-01|Meiji Dairies Corp|Nutritional compositions for liver disease patients or for patients underhigh levels of invasive stress|
    US20050148504A1|2002-11-29|2005-07-07|Nobuhiko Katunuma|Cysteine protease inhibitor|
    CN104703601A|2012-07-03|2015-06-10|格雷斯兰生物科技股份有限公司|Compositions and methods for treating and inhibiting viral infections|
    ES2444299B1|2012-08-23|2014-12-12|Nutrición Técnica Deportiva, S.L.|Use of a casein hydrolyzate as an antiherpetic agent|KR102073824B1|2018-04-11|2020-02-05|강원대학교산학협력단|Health functional food for protecting liver and preparing method thereof|
    FR3083981B1|2018-07-20|2021-01-15|Semiocare Sas|COMPOSITIONS FOR COSMETIC AND DERMATOLOGICAL USE|
    法律状态:
    2015-05-28| PC2A| Transfer of patent|Owner name: NTD LABS, S.L. Effective date: 20150522 |
    2016-06-06| FG2A| Definitive protection|Ref document number: 2544153 Country of ref document: ES Kind code of ref document: B1 Effective date: 20160606 |
    2021-10-04| FD2A| Announcement of lapse in spain|Effective date: 20211004 |
    优先权:
    申请号 | 申请日 | 专利标题
    ES201430248A|ES2544153B1|2014-02-24|2014-02-24|Use of a casein hydrolyzate as an antiviral agent|ES201430248A| ES2544153B1|2014-02-24|2014-02-24|Use of a casein hydrolyzate as an antiviral agent|
    US15/121,080| US10772927B2|2014-02-24|2015-02-17|Use of a casein hydrolysate as an antiviral agent|
    EP15710916.6A| EP3110430B1|2014-02-24|2015-02-17|Use of a casein hydrolysate as an antiviral agent|
    ES15710916T| ES2746523T3|2014-02-24|2015-02-17|Use of a casein hydrolyzate as an antiviral agent|
    PT157109166T| PT3110430T|2014-02-24|2015-02-17|Use of a casein hydrolysate as an antiviral agent|
    DK15710916.6T| DK3110430T3|2014-02-24|2015-02-17|USE OF CASEINE HYDROLYSATE AS AN ANTIVIRAL AGENT|
    PCT/IB2015/051157| WO2015125067A1|2014-02-24|2015-02-17|Use of a casein hydrolysate as an antiviral agent|
    [返回顶部]